Bone Biologics Corporatio... (BBLG)
0.83
-0.06 (-6.61%)
At close: Mar 03, 2025, 3:59 PM
0.80
-3.94%
After-hours: Mar 03, 2025, 05:28 PM EST
Bone Biologics Income Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | n/a | n/a | n/a | n/a | n/a | 50.00 | 96.00 | 96.00 | 700.00 | 4.45K | 877.78K | n/a | n/a | 3K | 3K | 3K | n/a |
| Gross Profit | n/a | n/a | n/a | n/a | n/a | -50 | -96 | -96 | -700 | -4.45K | -877.78K | n/a | n/a | -3K | -3K | -3K | n/a |
| Operating Income | -4.22M | -9.43M | -3.67M | -1.1M | -825.01K | -2.45M | -2.79M | -2.63M | -17.85M | -12M | -3.01M | -671.99K | -435.66 | -3K | -3K | -3K | -13.34K |
| Interest Income | 55.66K | 1.87K | 731.71 | 805.11 | 998.08 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Pretax Income | -7.32M | -8.95M | -1.48M | -1.61M | -1.82M | -3.42M | -4.43M | -7.05M | -21.03M | -13.87M | -4.42M | -1.08M | -714.76 | n/a | n/a | n/a | -13.34K |
| Net Income | -7.32M | -8.95M | 695.93K | -1.61M | -1.82M | -3.42M | -4.43M | -7.05M | -21.03M | -13.88M | -4.42M | -1.08M | -715.57 | n/a | n/a | n/a | -13.34K |
| Selling & General & Admin | 2.09M | 2.52M | 2.09M | 1.02M | 484.34K | 1.35M | 2.69M | 3.82M | 6.25M | 8.33M | 1.51M | 483.75K | 180.09 | n/a | n/a | n/a | n/a |
| Research & Development | 2.13M | 6.91M | 1.58M | 82.04K | 340.67K | 1.1M | 104.49K | -1.19M | 11.6M | 3.67M | 623.52K | 188.24K | 255.57 | n/a | n/a | n/a | n/a |
| Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | 104.49K | 2.63M | n/a | n/a | -9.62K | n/a | n/a | n/a | n/a | n/a | -13.34K |
| Operating Expenses | 4.22M | 9.43M | 3.67M | 1.1M | 825.01K | 2.45M | 2.79M | 2.63M | 17.85M | 12M | 3.01M | 671.99K | 435.66 | n/a | n/a | n/a | -13.34K |
| Interest Expense | n/a | n/a | n/a | 805.11K | 998.08K | 975.77K | 1.23M | 4.42M | 3.17M | 1.87M | 1.4M | n/a | n/a | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | n/a | 9.43M | 3.67M | 1.1M | 825.01K | 2.45M | 2.79M | 2.63M | 17.85M | 12M | 3.01M | 671.99K | 435.66 | 3K | 3K | 3K | -13.34K |
| Income Tax | n/a | n/a | -2.18M | 1.6K | 1.6K | 1.6K | 1.73K | 1.6K | 2.24K | 8.84K | 1.6K | 800.00 | 0.80 | n/a | n/a | n/a | n/a |
| Shares Outstanding (Basic) | 1.52M | 263.14K | 47K | 43K | 51K | 51K | n/a | n/a | n/a | n/a | n/a | n/a | 14.00 | 5M | 5M | 5M | 5M |
| Shares Outstanding (Diluted) | 1.52M | 263.14K | 47.66K | 43.13K | 51.14K | 51.14K | n/a | n/a | n/a | n/a | n/a | n/a | 14.57 | 5M | 5M | 5M | 5M |
| EPS (Basic) | -4.83 | -34.01 | -31.15 | -37.35 | -35.68 | -66.97 | n/a | n/a | n/a | n/a | n/a | n/a | -49.11 | n/a | n/a | n/a | -0.00 |
| EPS (Diluted) | -4.83 | -34.01 | -31.15 | -37.35 | -35.68 | -66.97 | n/a | n/a | n/a | n/a | n/a | n/a | -49.11 | n/a | n/a | n/a | -0.00 |
| EBITDA | -4.22M | 479.57K | n/a | n/a | -825.01K | -2.45M | -2.79M | -2.63M | -20.41M | -11.99M | -3.02M | n/a | -5.23K | -4.52K | -3K | -3K | -13.34K |
| Depreciation & Amortization | n/a | 9.43M | 3.67M | 1.1M | 50.00 | 50.00 | 96.00 | 96.00 | 700.00 | 4.45K | 280.00 | 671.99K | 435.66 | n/a | n/a | n/a | n/a |